Background &amp; aims <p>Currently, there are no approaches to specifically target macrophage-hepatic stellate cell (HSC) crosstalk in metabolic dysfunction-associated steatohepatitis (MASH). Although the β-catenin signaling pathway has been implicated in fibrotic diseases, the role and downstream mechanism of macrophage β-catenin in MASH-associated hepatic fibrosis remains incompletely understood.</p> Methods <p>Myeloid-specific β-catenin deficiency (β-catenin<sup>M−KO</sup>) mice and the floxed β-catenin (β-catenin<sup>FL/FL</sup>) mice were subjected to high-fat diet (HFD) feeding for 28 weeks. We delivered indian hedgehog (Ihh) plasmid in vivo using polyethylenimine nanoparticles, in vivo jetPEI-Man, that specifically deliver to macrophages.</p> Results <p>Although increased β-catenin activation was observed in the fibrotic liver macrophages of mice after HFD feeding, myeloid-specific β-catenin deficiency protected the liver against HFD-induced steatosis and fibrosis. Furthermore, we found that myeloid-specific β-catenin deficiency suppressed Ihh expression in liver macrophages. In vivo jetPEI-Man-mediated Ihh restoration prevented the improvement in MASH-induced fibrosis that we observed in β-catenin<sup>M−KO</sup> mice. In vitro co-culture experiments indicated that β-catenin activation in macrophages induced Ihh expression and secretion, which then promoted the activation of HSCs.</p> Conclusion <p>Our findings identify the macrophage β-catenin-Ihh axis as a key regulator for controlling hepatic steatosis and fibrosis during MASH.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Macrophage β-catenin-Ihh axis induces hepatic stellate cell activation and fibrosis in metabolic dysfunction-associated steatohepatitis

  • Rongsheng Zhang,
  • Yelin Yang,
  • Feng Xiao,
  • Yifei He,
  • YunXia Chai,
  • Jiajing Qiu,
  • Qiang Zhu,
  • Wenjie Sun,
  • Mingzheng Chen,
  • Zhongya Xu

摘要

Background & aims

Currently, there are no approaches to specifically target macrophage-hepatic stellate cell (HSC) crosstalk in metabolic dysfunction-associated steatohepatitis (MASH). Although the β-catenin signaling pathway has been implicated in fibrotic diseases, the role and downstream mechanism of macrophage β-catenin in MASH-associated hepatic fibrosis remains incompletely understood.

Methods

Myeloid-specific β-catenin deficiency (β-cateninM−KO) mice and the floxed β-catenin (β-cateninFL/FL) mice were subjected to high-fat diet (HFD) feeding for 28 weeks. We delivered indian hedgehog (Ihh) plasmid in vivo using polyethylenimine nanoparticles, in vivo jetPEI-Man, that specifically deliver to macrophages.

Results

Although increased β-catenin activation was observed in the fibrotic liver macrophages of mice after HFD feeding, myeloid-specific β-catenin deficiency protected the liver against HFD-induced steatosis and fibrosis. Furthermore, we found that myeloid-specific β-catenin deficiency suppressed Ihh expression in liver macrophages. In vivo jetPEI-Man-mediated Ihh restoration prevented the improvement in MASH-induced fibrosis that we observed in β-cateninM−KO mice. In vitro co-culture experiments indicated that β-catenin activation in macrophages induced Ihh expression and secretion, which then promoted the activation of HSCs.

Conclusion

Our findings identify the macrophage β-catenin-Ihh axis as a key regulator for controlling hepatic steatosis and fibrosis during MASH.